Who is the ideal patient for tapinarof, and are there any notable exclusions?
Featuring Tina Bhutani, MD, MAS | CEO, Synergy Dermatology Associate Clinical Professor of Dermatology University of California, SF San Francisco, CA | Published April 08, 2024
Related Media
Powered by Polaris TM